Point72 (DIFC)’s BioCryst Pharmaceuticals BCRX Stock Holding History

Point72 (DIFC)’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$67.5K	Buy
2024 Q3	–	Sell
2024 Q2	$411K	Buy
2024 Q1	$48.4K	Buy